2016
DOI: 10.1016/j.foodres.2016.01.032
|View full text |Cite
|
Sign up to set email alerts
|

Current encapsulation strategies for bioactive oils: From alimentary to pharmaceutical perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
122
0
10

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 204 publications
(132 citation statements)
references
References 168 publications
0
122
0
10
Order By: Relevance
“…The performance of encapsulated bioactive compounds in food systems depends on their release behavior (Rodríguez, Martín, Ruiz, & Clares, 2016). Among nanocarrier systems, nanoliposomes have a high ability to improve targeted and controlled release of bioactive materials (Khorasani et al, 2018).…”
Section: In Vitro Releasementioning
confidence: 99%
“…The performance of encapsulated bioactive compounds in food systems depends on their release behavior (Rodríguez, Martín, Ruiz, & Clares, 2016). Among nanocarrier systems, nanoliposomes have a high ability to improve targeted and controlled release of bioactive materials (Khorasani et al, 2018).…”
Section: In Vitro Releasementioning
confidence: 99%
“…Thus, encapsulation and particularly, nanoencapsulation, is one of the most efficient methods for the formulation of active substances, being a viable and efficient approach to increasing its physical stability and protecting them from interactions with environmental factors, such as, pH, oxygen, light and moisture. [18][19][20] For example, solid lipid microparticles (SLM) were used to encapsulate juniper oil, in order to reduce the volatility of the antimicrobial agent, applied to treatment of acne vulgare. 21 The encapsulation of eugenol and carvacrol into nanometric surfactant micelles for the solubilization in the aqueous phase also resulted in enhanced antimicrobial activity against two pathogenic bacteria.…”
mentioning
confidence: 99%
“…In general, extrusion technologies are performed under mild conditions (pressure and temperature are generally lower than 700 kPa and 118 °C) [18], they do not utilize any harmful solvents and it is possible to use these technologies for encapsulation of bioactives in both anaerobic and aerobic conditions; all listed make them applicable for encapsulation of sensitive bioactives, such as heat-sensitive products, as well as living cells. In addition, the microbeads produced by extrusion technologies have less porous structure when compared to those produced for example by means of spray-drying process [19]. However, the major drawbacks of extrusion…”
Section: Extrusion Technologiesmentioning
confidence: 99%